Twist Bioscience (TWST) just rolled out research grade Plasmid DNA Preps tailored for pre clinical pharma and biotech work, a small but telling move that helps explain the recent uptick in the stock.
Plasmid Purification Market to reach USD 6.6 Bn by 2035 at 12.3% CAGR, Driven by rising gene therapy demand, mRNA vaccines, ...
A new single-cell system visualizes plasmid competition, exposing how mobile genetic elements evolve and spread resistance.
Genenta Science S.p.A. initiating with a Buy rating following a 90% stock surge after announcing a strategic partnership with ANEMOCYTE for LVV plasmid DNA technology. GNTA's lead cell therapy, ...
Investing.com -- Genenta Science (NASDAQ:GNTA) stock soared 241.8% in premarket trading Friday after announcing a strategic collaboration with ANEMOCYTE focused on off-the-shelf lentiviral vector ...
ROCKVILLE, Md., Oct. 8, 2025 /PRNewswire/ -- Ascend Advanced Therapies (Ascend), a gene-to-GMP development partner, today announced that its European patent EP3722434, protecting EpyQ®, the company's ...
VectorBuilder, a global leader in gene delivery technologies and CDMO services, today announced the publication of the miniVec plasmid system, engineered for safer, more efficient, and more scalable ...
Bionova Scientific, a full-service biologics contract development and manufacturing organization (CDMO) and subsidiary of global conglomerate Asahi Kasei, has announced the opening of a 10,000 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback